Aimatologos.gr

ΔΗΜΟΣΙΕΥΣΕΙΣ
1. Mimidis K., Tsatalas C., Margaritis D., Martinis G., Spanoudakis E., Kotsiou S.,
Kartalis G., Bourikas G. Efficacy of Lamivudine in patients with hematologic
malignancies receiving chemotherapy and precore mutant chronic active hepatitis
B.ActaHaematol. 2002;107(1):49-51.
2.Tsatalas C, Martinis G., D. Margaritis, E. Spanoudakis, I. Kotsianidis, A. Karpouzis, G.
Bourikas. Long-term remission of recalcitrant tumour-stage mycosis fungoides
following chemotherapy with pegylated liposomal doxorubicin. J
EurAcadDermatolVenereol. 2003 Jan;17(1):80-2.
3.Tsatalas C., Margaritis D., Pantelidou D., Spanoudakis E., Kaloutsi V., Bourikas
G.Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-
cell lymphoma with fludarabine.ActaHaematol. 2003;109(2):110.
4. C. Tsatalas, D. Margaritis, D. Pantelidou, I. Kotsianidis, A.J. Karayannakis, E.
Spanoudakis, Z. Kartasis, V. Kaloutsi, A. Polychronidis, I. Manavis, G. Bourikas.
Splenectomy for massive splenic infarction unmasks paroxysmal nocturnal
hemoglobinuria. ActaHaematol 2003;110(4):193-95.
5. K. Mimidis, V. Papadopoulos, I. Kotsianidis, D. Filippou, E. Spanoudakis, G.
Bourikas, C. Dervenis, G. Kartalis. Αlterations of platelet function, number and indexes
during acute pancreatitis.Pancreatology2004;4(1):22-7.
6.C. Tsatalas, E. Spanoudakis, D. Pantelidou, D. Margaritis, I.Kotsianidis, P. Chalkia, G.
Tripsianis, I. Basdiara, Z. Kartasis, A. Karakolios, G.Bourikas.
AmifostineStimulatesTheFormationOfHaematopoieticBoneMarrowProgenitorsFromB-
cellChronicLymphocyticLeukemia (B-CLL).ActaHaematol. 2004;112(3):136-40.
7. Pantelidou D., Tsatalas C., Margaritis D., Kaloutsi V., Spanoudakis E., Bourikas
G.Anti-CD20 monoclonalantibodyrituximabforthetreatmentofB-
cellchroniclymphocyticleukemia-
associatedpureredcellaplasia.Heamatol.J.2004;5(6):546-7.
8. Pantelidou D., Tsatalas C., Margaritis D., Karayiannakis AJ., Kaloutsi V., Spanoudakis
E., Katsileris I., Chatzipaschalis E., Sivridis E., Bourikas G. Extramedullaryplasmacytoma:
report of two cases with uncommon presentation. Ann. Hematol. 2005 Mar;84(3):188-
91.
9.Ioannis Kotsianidis, Jonathan D. Silk, Emmanouil Spanoudakis, Scott Patterson,
Antonio Almeida, Richard R. Schmidt, Costas Tsatalas, George Bourikas, Vincenzo
Cerundolo, Irene A. G. Roberts, and Anastasios Karadimitris Regulation of
hematopoiesis in vitro and in vivo by invariant NKT cells. Blood, 15 April 2006, Vol.
107, No. 8, pp. 3138-3144.
10.AnastasiosKaradimitris, Scott Patterson, Emmanouil Spanoudakis. NKT and
Haemopoiesis. Review article. British Journal of Haematology. 2006. Aug; 134(3):
105-10.
11.Matsouka P., Pagoni M., Zikos P., Giannakoulas N., Apostolidis I., Asprogeraka T.,
Arvanitopoulou E., Spanoudakis E., Kotsianidis I., Tsatalas C., Papaioannou M.,
Marinakis G., Megalakakis A., Skandala., Viniou N., Yataganas X., Bakiri M.
Additionofcyclosporin-Atochemotherapyinsecondary (post-MDS) AMLintheelderly. A
multicenter randomized trial of the Leukemia Working Group of the Hellenic Society
of Hematology. AnnHematol. 2006 Apr;85(4):250-6.
12.Stakos DA., Kotsianidis I., Tziakas D., Spanoudakis E.,Chalkias G., Bourikas G.,
Katsaris G., Boudoulas H. Leukocyte activation after coronary stenting in patients
during the subacute phase of a previous ST-elevation myocardial infarction. Coron
Art Disease Mar 2007; 18(2): 105-110.
13. E. Spanoudakis, D. Margaritis, I. Kotsianidis, G. Georgiou G. Tripsianis, A.
Anastasiadis,A. Karakolios, D. Pantelidou, P. Panayiotidis, G. Bourikas, C.
Tsatalas.Long Term Bone Marrow Cultures (LTBMC) from Essential Thrombocythemia
(ET) patients with or without JAK2617V>F mutation. Leukemia Research, March
2008.(32); 1593-1596.
14. I.Kotsianidis, I. Basdiara, Α. Anastasiades, E. Spanoudakis, D. Pantelidou, D.
Margaritis, G.Bourikas, De Coster R., De Porre P.,C. Tsatalas. In-vitro effects of
farnesyltransferase inhibitor Tipifarnib on Myelodysplastic syndrome progenitors.
ActaHaematologica 2008;120(1):51-56.
15.Emmanouil Spanoudakis, IoannaBazdiara, IoannisKotsianidis, DimitriosMargaritis,
AggelosGoutzouvelidis, Anna Christoforidou, Costas Tsatalas& George Bourikas.
Hydroxyurea (HU) is effective in reducing JAK2V617F mutated clone size in the
peripheral blood of essential thrombocythemia (ET) and polycythemia vera (PV)
patients. Ann Haematol 2009 Jul; 88(7): 629-32.
16.KotsianidisI, BouchliouI, NakouE, Spanoudakis E, MargaritisD, ChristophoridouAV,
AnastasiadesA, TsigalouC, BourikasG, KaradimitrisA, TsatalasC.Kinetics, function and
bone marrow traffickingof CD4+CD25highFoxp3+ regulatory T cells in Myelodysplastic
Syndromes (MDS). Leukemia. Mar 2009;23:pp510-18.
17. Spanoudakis E, Hu M, Naresh K, Terpos E, Melo V, Reid A,Kotsianidis I, A.
Rahemtulla A, Karadimitris A. Regulation of multiple myeloma survival and
progression by CD1d.Blood; 12 Μαρ 2009;113:pp 2498-2507.
18.Avloniti A., Douda H., Tokmakidis S., Kortsaris A., Papadopoulou E. & Spanoudakis
E. Acute effects of soccer training onwhite blood cells count in elite female patients.
JSportPhysiolandPerformance. 2007; 2: 239-249.
19. E. Spanoudakis, C. Tsatalas.Hemopoiesis in Ph-negative Myeloproliferative
disorders. Review Article. Current Stem Cell Research and Therapy. 2009 May;4(2):
154-60.
20.Christoforidou A, Pantelidou D, Anastasiadis A, Goutzouvelidis A, Margaritis D,
Kotsianidis I, Spanoudakis E, Kaloutsi V, Bourikas G, Tsatalas C. Hydroxyurea and
anagrelide combination therapy in patients with chronic myeloproliferative disorders
resistant or intolerant to monotherapy. ActaHaematologica. Jan 2009;120(4): 195-8.
21. Kotsianidis I, Nakou E, Bouchliou I, Tzouvelekis A, Spanoudakis E,
Steiropoulos P, Sotiriou I, Aidinis V, Margaritis D, Tsatalas C. and Bouros D.
Global impairment of CD4+cd25+Foxp3+ T-Regulatory cells in idiopathic
pulmonary fibrosis. American Journal of Respiratory and Critical Care
Medicine. 2009 Jun 15; 179(12): 1121-30.
22. Tsatalas C, Chalkia P, Pantelidou D, Margaritis D, Bourikas G, Spanoudakis E.
Pregnancy in β-thalassemia trait carriers: an uneventfull journey. ReviewArticle.
Hematology. 2009 Oct;14(5):301-3.
23.Anastasiadis A, Margaritis D, Kotsianidis I, Spanoudakis E, Christoforidou A,
Kostopoulos I, Tsatalas C. Pure red cell aplasia as first manifestation of splenic
marginal zone lymphoma-successful treatment with rituximab: a case report.Cases J.
2009 Aug 18;2:6913.
24. Kotsianidis I, Goutzouvelidis A, Anastasiades A, Bouchliou I, Nakou E,
Spanoudakis E, Christophoridou AV, Margaritis D, Bourikas G, Tsatalas C.Severe
thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation
after rituximab infusion.Am J Hematol. 2010 Feb;85(2):146.
25. Spanoudakis E, Bazdiara I, Pantelidou D, Kotsianidis I, Papadopoulos V,
Margaritis D, Xanthopoulidis G, Moustakidis E, Mantzourani S, Bourikas G, Tsatalas
C.Dynamics of telomere's length and telomerase activity in Philadelphia
chromosome negative myeloproliferativeneoplasms.Leuk Res. 2011 Apr;35(4):459-64. 26.Hu M, Bassett JH, Danks L, Howell PG, Xu K, Spanoudakis E, Kotsianidis I, Boyde A,
Williams GR, Horwood N, Roberts IA, Karadimitris A.Activated invariant NKT cells
regulate osteoclast development and function.JImmunol. 2011 Mar 1;186(5):2910-7.
27.Bouchliou I, Miltiades P, Nakou E, Spanoudakis E, Goutzouvelidis A, Vakalopoulou
S, Garypidou V, Kotoula V, Bourikas G, Tsatalas C, Kotsianidis I.Th17 and Foxp3(+) T
regulatory cell dynamics and distribution in myelodysplasticsyndromes.ClinImmunol.
2011 Jun;139(3):350-9.
28. Vadikolia CM, Tsatalas C, Anagnostopoulos K, Trypsianis G, Pantelidou D,
Bazdiara I, Anastasiadis A, Spanoudakis E, Kotsianidis I, Margaritis D, Kortsaris A,
Bourikas G.Proteolytic matrix metallopeptidases and inhibitors in BCR-ABL1-negative
myeloproliferative neoplasms: correlation with JAK2 mutation status.ActaHaematol.
2011;126(1):54-62.
29. Kotsianidis I, Nakou E, Spanoudakis E, Bouchliou I, Moustakidis E, Miltiades P,
Vadikolia CM, Szydlo R, Karadimitris A, TsatalasC. The diagnostic value of CD1d
expression in a large cohort of patients with B-cell chronic
lymphoproliferativedisorders. Am J ClinPathol. 2011 Sep;136(3):400-8.
30. Courcoutsakis N, Spanoudaki A, Maris TG, Astrinakis E, Spanoudakis E, Tsatalas C,
PrassopoulosP.Perfusion parameters analysis of the vertebral bone marrow in
patients with Ph¹⁻ chronic myeloproliferative neoplasms (Ph(neg) MPN): a dynamic
contrast-enhanced MRI (DCE-MRI) study.JMagnReson Imaging. 2012 Mar;35(3):696-
702.
31. Kotsianidis I, Spanoudakis E, Nakou E, Miltiades P, Margaritis D, Tsatalas C,
Tzouvelekis A, OikonomouA.Hypomethylating therapy and autoimmunity in MDS: An
enigmatic relationship.Leuk Res. 2012 Apr;36(4):e90-2.
32. Nakou E, Babageorgakas P, Bouchliou I, Tziakas DN, Miltiades P, Spanoudakis E,
Margaritis D, Kotsianidis I, Stakos DA. Statin-Induced Immunomodulation Alters
Peripheral Invariant Natural Killer T-cell Prevalence in Hyperlipidemic Patients
Cardiovasc Drugs Ther. 2012 Mar 24.

Source: http://www.aimatologos.gr/var/m_8/8a/8a9/181023/88212-dimosiefsis.pdf